Mount Sinai Hospital

Running trials

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Source

• Recruiting

  Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing

  NCT07387263· Source

• Recruiting

  Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares

  NCT07245732· Phase 4· Source

• Recruiting

  The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

  NCT06455384· Source

• Recruiting

  Activation Sarcoma: PROMIS and Mobility Evaluation in Sarcoma Patients

  NCT07227961· Source

• Recruiting

  Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic

  NCT06805773· Source

• Enrolling by invitation

  Clinical Utility of ClarityDX Prostate

  NCT06678828· Source

• Enrolling by invitation

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  NCT06823115· Source

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Source

• Active, not recruiting

  Evaluation of a Simple-Prep Controlled Embolic

  NCT06453642· Source

• Recruiting

  Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women (PART II)

  NCT06655675· Source

• Active, not recruiting

  A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.

  NCT06116136· Phase 1/2· Source

• Recruiting

  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  NCT06226883· Phase 2· Source

• Recruiting

  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  NCT06252649· Phase 3· Source

• Recruiting

  Effectiveness of Two Different Body Positions During Facemask Ventilation in Obese Patients

  NCT06305273· Source

• Recruiting

  This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

  NCT06805669· Source

• Recruiting

  Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study

  NCT06285396· Source

• Recruiting

  A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  NCT06233461· Phase 2· Source

• Active, not recruiting

  Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06029972· Phase 2· Source

• Recruiting

  A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

  NCT05762107· Phase 2· Source

• Recruiting

  Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)

  NCT05114096· Phase 4· Source

• Active, not recruiting

  Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring

  NCT04972955· Source

• Recruiting

  Type 1 Diabetes Virtual Self-management Education and Support

  NCT05756829· Source

• Recruiting

  A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

  NCT05253651· Phase 3· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

  NCT05347095· Phase 3· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382286· Phase 3· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382299· Phase 3· Source

• Active, not recruiting

  A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

  NCT05132582· Phase 3· Source

• Recruiting

  Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study

  NCT04973397· Source

• Recruiting

  Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program

  NCT04895839· Source

• Recruiting

  RA-PRO PRAGMATIC TRIAL

  NCT04692493· Phase 3· Source

• Recruiting

  Diet Intervention Treatment for Active Ulcerative Colitis

  NCT04121806· Source

• Recruiting

  Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

  NCT04031677· Phase 3· Source

• Active, not recruiting

  Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)

  NCT03941132· Phase 2/3· Source

• Active, not recruiting

  Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

  NCT04524611· Phase 3· Source

• Active, not recruiting

  Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

  NCT04068103· Phase 2/3· Source

• Active, not recruiting

  Association of Body Fluid Distribution With Obstructive Sleep Apnea in Pregnant Women With Body Mass Index ≥ 40 kg/m2

  NCT04187612· Source

• Active, not recruiting

  Surveillance AFter Extremity Tumor surgerY

  NCT03944798· Source

• Active, not recruiting

  Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

  NCT04041310· Phase 1/2· Source

• Active, not recruiting

  An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

  NCT03950232· Phase 3· Source

• Active, not recruiting

  Fit-for-Fertility Multicenter Randomized Controlled Trial

  NCT03908099· Source

• Active, not recruiting

  Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

  NCT03765450· Source

• Active, not recruiting

  Effects of Telemonitoring on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation

  NCT03358303· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

  NCT03105102· Phase 3· Source

• Active, not recruiting

  Critical Care Outcomes of Hematologic Oncology Patients

  NCT03449953· Source

• Active, not recruiting

  Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

  NCT03168815· Source

• Active, not recruiting

  Breast Cancer WEight Loss Study (BWEL Study)

  NCT02750826· Phase 3· Source

• Recruiting

  Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

  NCT02906943· Source

• Active, not recruiting

  Preoperative vs Postoperative IMRT for Extremity/Truncal STS

  NCT02565498· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Sarcoma4 recruiting
• Colorectal cancer3 recruiting
• Prostate cancer3 recruiting
• Crohn's disease2 recruiting
• High blood pressure2 recruiting
• Rheumatoid arthritis2 recruiting
• Type 1 diabetes2 recruiting
• Type 2 diabetes2 recruiting
• ANCA-associated vasculitis1 recruiting
• Asthma1 recruiting
• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Epilepsy1 recruiting
• Gastric and esophageal cancer1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Acorai Machine Learning Generalization (MLG) Study

  NCT05835024· Source

• Completed

  RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

  NCT05513560· Phase 2/3· Source

• Completed

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· Phase 2· Source

• Completed

  IBD Neoplasia Surveillance RCT

  NCT05809999· Source

• Completed

  The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial

  NCT05025852· Source

• Completed

  Optimum Length of Catheter in the Epidural Space for Labor Analgesia in Non-obese Women: a Randomised Controlled Trial of 4 cm Versus 5 cm

  NCT04946032· Source

• Completed

  Family History App in Personalized Medicine

  NCT04726319· Source

• Completed

  Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT)

  NCT04902378· Source

• Completed

  Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

  NCT04440592· Phase 2· Source

• Completed

  The Effect of a Head Elevated Positioning Device on Position, Height and Depth of the Cricothyroid Membrane in Morbidly Obese Pregnant Women in the Third Trimester.

  NCT04569539· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Source

• Completed

  Interactive Online Informational and Peer Support App for Patients with Low Anterior Resection Syndrome

  NCT04469426· Source

• Completed

  A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

  NCT03819153· Phase 3· Source

• Completed

  Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

  NCT03261206· Phase 4· Source

• Completed

  Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension

  NCT04402645· Source

• Completed

  Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease

  NCT03397108· Source

• Completed

  A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

  NCT03213457· Phase 3· Source

• Completed

  Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

  NCT03376438· Source

• Completed

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· Phase 3· Source

• Completed

  Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

  NCT02108860· Phase 3· Source

• Completed

  A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants

  NCT02075840· Phase 3· Source

• Completed

  The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

  NCT01940094· Phase 3· Source

• Recruiting

  Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

  NCT00315380· Source

Trial sites

• Mount Sinai Hospital60 trials
• Mount Sinai Hospital (Canada)1 trial
• Mount Sinai Hospital /ID# 1697641 trial
• Mount Sinai Hospital /ID# 2237521 trial
• Mount Sinai Hospital: Leadership Sinai Centre for Diabetes1 trial
• Mount Sinai Hospital, The Rebecca Macdonald Centre For Arthritis And Autoimmune Disease1 trial
• Mount Sinai Hospital Toronto6 trials
• Mount Sinai Hospital/UHN1 trial
• Mount Sinai Hospital, University of Toronto1 trial
• Mount Sinai Hosp.-Toronto /ID# 1489721 trial
• University of Toronto - Mount Sinai Hospital - The Lunenfeld-Tanenbaum Research Institute1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Crohn's disease53 works · 8 trials
• Sarcoma35 works · 6 trials
• Ulcerative colitis23 works · 5 trials
• ANCA-associated vasculitis7 works · 4 trials